Blood management for anemic patients having bypass surgery
Treatments studied
Part of Blood & lymphatic, Heart & circulation clinical trials.
This trial tests a blood management strategy to help people with anemia who are having coronary artery bypass surgery (CABG). If you qualify, you may receive a treatment to improve your blood counts before surgery, which could reduce the need for transfusions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your surgery is planned ahead of time (not an emergency).
- You are having only coronary artery bypass grafting — no other heart procedures.
- Your surgeon plans to do the bypass without stopping your heart (off-pump).
- You are not older than 80.
- Your hemoglobin levels are between 8 and 13 g/dL for men, or between 8 and 12 g/dL for women.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether collecting and re-infusing your own blood during heart surgery reduces the need for donor blood transfusions. It's for adults having planned bypass surgery with a heart-lung machine.
This study tests whether a personalized plan for when to give blood transfusions works better than the usual approach in people having heart surgery with a heart-lung machine. The goal is to find a safer and more effective way to manage transfusions during recovery.
This trial studies a program to manage blood levels before, during, and after heart surgery. It may help reduce the need for blood transfusions and improve recovery.
This trial is testing whether giving iron plus vitamin C before heart surgery can reduce the need for blood transfusions. It is for people with low iron and anemia who are scheduled for bypass or valve surgery.
This study looks at how hospitals manage your blood during and after planned surgeries that have a moderate to high risk of bleeding. It aims to find better ways to reduce blood loss and the need for transfusions.
This trial tests a combined treatment plan to improve anemia (low blood count/iron levels) before and around the time of major elective heart surgery. It may help reduce the need for blood transfusions and support safer recovery.
Hear when a new Anemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.